Nonarteritic, anterior ischemic optic neuropathy can occur at any age although it is more common in older White adults (mean age of onset, 60 years) and is slightly more common in men than women ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

HealthDay News — Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to ...

A deep learning system achieved an accuracy of more than 90% in distinguishing arteritic from nonarteritic anterior ischemic optic neuropathy using only color fundus images, according to a study ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a study published online Dec ...

About The Study: The findings of this study suggest an association between semaglutide, a glucagon-like peptide 1 receptor agonist, and nonarteritic anterior ischemic optic neuropathy. As this was ...

Semaglutide was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy — a form of optic neuropathy that can cause blindness — in adults with type 2 diabetes or ...

Ischemic optic neuropathies are the most common acute optic nerve pathology in patients older than 50 years of age. A 62-year-old Asian man presents to the emergency department with a complaint of ...

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...

(HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to ...